Weekly Fungal Diagnostics Update: Key Papers and Trends (20th April 2026)

Posted on by

Last reviewed: 20 April 2026

This week’s fungal diagnostics papers highlight a clear pattern: tests are becoming broader, faster, and more technically capable, but interpretation remains the difficult part. In particular, several papers focused on the challenge of telling true invasive infection from colonisation, and on how newer molecular and pathology-based methods might improve decision-making.

Below is a short roundup of the most relevant papers from this week’s diagnostic searches, with links out to PubMed and a brief note on why each paper matters.

Key points

  • Metagenomic next-generation sequencing (mNGS) continues to attract attention, especially for invasive pulmonary aspergillosis, but interpretation remains a major limitation.
  • Reviews of invasive mould diagnostics suggest the field is moving quickly, but not every promising test is ready for routine use.
  • Histopathology still matters, but morphology alone may not always be enough for accurate genus-level diagnosis.
  • Rapid antifungal susceptibility testing is becoming more important, especially where azole resistance is a concern.
  • Diagnostic stewardship matters too: better testing is not only about new technologies, but also about using current tests appropriately.

This week’s most relevant fungal diagnostics papers

1) Blood metagenomic next-generation sequencing for invasive pulmonary aspergillosis

Chen Y, Tang X, Lu S, Guo L, Wang L, Min L, Niu T, Zhou Y.
The diagnostic and prognostic utility of blood metagenomic next-generation sequencing for invasive pulmonary aspergillosis.
Microbiol Spectr. 2026 Apr 17:e0338425. doi: 10.1128/spectrum.03384-25.
PMID: 41995327
View on PubMed

Why it matters: This is one of the strongest papers in this week’s set because it tackles a major real-world problem: how to interpret a positive fungal signal from a broad molecular test. Blood mNGS may help detect Aspergillus more quickly, but a positive result does not automatically mean a person has invasive disease.

Take-home message: mNGS looks promising, but its real value depends on combining the result with other clinical information and fungal biomarkers to help separate invasive infection from colonisation.

2) Laboratory innovations to diagnose invasive mould infections – what is relevant, what is not?

Vanbiervliet Y, Aerts R, Maessen L, Wauters J, Maertens J, Lagrou K.
Laboratory innovations to diagnose invasive mould infections – what is relevant, what is not?
Clin Microbiol Infect. 2026 May;32(5):715-728. doi: 10.1016/j.cmi.2025.10.017.
PMID: 41173342
View on PubMed

Why it matters: This review is one of the best “state of the field” papers in the batch. It discusses newer approaches such as metagenomic next-generation sequencing, Aspergillus antigen detection, and emerging laboratory strategies for invasive mould infections.

Take-home message: The technology is improving fast, but performance, practicality, cost, and interpretation still determine whether a test is genuinely useful in routine care.

3) How accurate is lung fungal diagnosis based on morphology alone?

Toro P, Doxtader E, Mukhopadhyay S.
Accuracy of Genus-Level Diagnosis of Fungal Organisms in Pathology Specimens from the Lung Based on Morphology Alone: Analysis of 52 Specimens with Microbiology/PCR as Gold Standard.
Int J Surg Pathol. 2026 May;34(3):603-611. doi: 10.1177/10668969251382760.
PMID: 41248033
View on PubMed

Why it matters: Histopathology remains an important part of fungal diagnosis, especially in severe disease, but this paper asks an important question: how reliable is morphology alone when trying to identify the fungal genus in lung samples?

Take-home message: Pathology is still valuable, but genus-level certainty may require confirmation by microbiology or polymerase chain reaction (PCR), particularly where treatment decisions depend on precise identification.

4) Rapid antifungal susceptibility testing for Aspergillus fumigatus using a LAMP-based method

Nozue S, Furuhashi K, Toguchi A, Ishikawa J, Nagura O, Yamashita K, Maekawa M, Iwaizumi M.
Rapid antifungal susceptibility testing for Aspergillus fumigatus using a loop-mediated isothermal amplification method.
J Microbiol Methods. 2026 May;244:107455. doi: 10.1016/j.mimet.2026.107455.
PMID: 41831694
View on PubMed

Why it matters: This study is especially relevant because it goes beyond detecting the fungus and looks at rapid testing for antifungal susceptibility. With rising concern about azole resistance, being able to get useful susceptibility information faster could become increasingly important.

Take-home message: Faster susceptibility testing could help shorten the time between detecting Aspergillus fumigatus and choosing the most appropriate treatment.

5) Are we over-testing galactomannan?

Bozkurt I.
Over-testing Galactomannan in patients with hematological malignancies: A retrospective analysis from a tertiary care university hospital in Türkiye.
Diagn Microbiol Infect Dis. 2026 May;115(1):117284. doi: 10.1016/j.diagmicrobio.2026.117284.
PMID: 41621371
View on PubMed

Why it matters: This paper is a useful reminder that diagnostics is not just about new technology. It also matters how often tests are ordered, in whom, and with what expected benefit. The authors found a low diagnostic yield from galactomannan testing in their cohort, raising questions about cost and efficiency.

Take-home message: Better fungal diagnostics also means using existing tests more thoughtfully and in the right clinical context.

6) Invasive mould infection in children – advances made or obstacles remaining?

Yeoh DK, Butters C, Clark JE, Slavin MA, McMullan BJ, Haeusler GM, Blyth CC.
Invasive mould infection in children – advances made or obstacles remaining?
Clin Microbiol Infect. 2026 May;32(5):740-748. doi: 10.1016/j.cmi.2025.11.023.
PMID: 41317867
View on PubMed

Why it matters: This review highlights an important diagnostic difficulty in paediatric invasive mould disease: imaging often helps raise suspicion, but findings can be non-specific and may not distinguish Aspergillus from other moulds.

Take-home message: Even with better diagnostics, invasive mould infection in children remains a difficult area where no single test gives all the answers.

7) Falcon plasma proteomics to improve avian aspergillosis diagnosis

Vieu S, Lozano C, Azmanis P, Beaudeau F, Guillot J, Armengaud J.
Falcon plasma proteomics to improve avian aspergillosis diagnosis.
J Proteomics. 2026 Apr 15;328:105659. doi: 10.1016/j.jprot.2026.105659.
PMID: 41990917
View on PubMed

Why it matters: This is not a human clinical paper, but it is still interesting from a diagnostics perspective because it explores biomarker discovery using proteomics. That makes it relevant to the wider question of whether future aspergillosis diagnosis could become less invasive and more biologically specific.

Take-home message: Biomarker discovery remains an active area of research, although translation into routine clinical practice is often slow.

8) Rapid phenotypic identification of Candida albicans compared with PCR

Jabri B, Faouzi S, Bouzit A, Chtibi H, Assimi S, Iken M.
A combined rapid phenotypic strategy for the identification of Candida albicans: Performance evaluation against PCR.
Diagn Microbiol Infect Dis. 2026 Jul;115(3):117388. doi: 10.1016/j.diagmicrobio.2026.117388.
PMID: 41880733
View on PubMed

Why it matters: Although not an aspergillosis paper, this study is still relevant to fungal diagnostics generally because it assesses rapid routine laboratory approaches against PCR.

Take-home message: Rapid phenotypic methods still have a role, but their accuracy needs careful validation against molecular standards.

Overall message

The main message from this week’s papers is that fungal diagnostics are improving, but there is still no single perfect test. Broad molecular methods such as metagenomic next-generation sequencing can increase sensitivity and widen detection, but they also create interpretation challenges. Histopathology remains important, but is strongest when combined with microbiology or PCR. At the same time, faster susceptibility testing may become increasingly valuable as resistance concerns grow. In other words, the field is moving toward faster and more sophisticated detection, but the real challenge remains translating results into confident clinical decisions.

References

  1. Chen Y, Tang X, Lu S, Guo L, Wang L, Min L, Niu T, Zhou Y. The diagnostic and prognostic utility of blood metagenomic next-generation sequencing for invasive pulmonary aspergillosis. Microbiol Spectr. 2026 Apr 17:e0338425. PMID: 41995327.
  2. Vanbiervliet Y, Aerts R, Maessen L, Wauters J, Maertens J, Lagrou K. Laboratory innovations to diagnose invasive mould infections – what is relevant, what is not? Clin Microbiol Infect. 2026 May;32(5):715-728. PMID: 41173342.
  3. Toro P, Doxtader E, Mukhopadhyay S. Accuracy of Genus-Level Diagnosis of Fungal Organisms in Pathology Specimens from the Lung Based on Morphology Alone: Analysis of 52 Specimens with Microbiology/PCR as Gold Standard. Int J Surg Pathol. 2026 May;34(3):603-611. PMID: 41248033.
  4. Nozue S, Furuhashi K, Toguchi A, Ishikawa J, Nagura O, Yamashita K, Maekawa M, Iwaizumi M. Rapid antifungal susceptibility testing for Aspergillus fumigatus using a loop-mediated isothermal amplification method. J Microbiol Methods. 2026 May;244:107455. PMID: 41831694.
  5. Bozkurt I. Over-testing Galactomannan in patients with hematological malignancies: A retrospective analysis from a tertiary care university hospital in Türkiye. Diagn Microbiol Infect Dis. 2026 May;115(1):117284. PMID: 41621371.
  6. Yeoh DK, Butters C, Clark JE, Slavin MA, McMullan BJ, Haeusler GM, Blyth CC. Invasive mould infection in children – advances made or obstacles remaining? Clin Microbiol Infect. 2026 May;32(5):740-748. PMID: 41317867.
  7. Vieu S, Lozano C, Azmanis P, Beaudeau F, Guillot J, Armengaud J. Falcon plasma proteomics to improve avian aspergillosis diagnosis. J Proteomics. 2026 Apr 15;328:105659. PMID: 41990917.
  8. Jabri B, Faouzi S, Bouzit A, Chtibi H, Assimi S, Iken M. A combined rapid phenotypic strategy for the identification of Candida albicans: Performance evaluation against PCR. Diagn Microbiol Infect Dis. 2026 Jul;115(3):117388. PMID: 41880733.